Pictor is an in-vitro diagnostics company that offers a patented multiplexed platform for highly accurate and efficient testing of complex and infectious diseases for human and animal health.  

Pictor's PictArray™ multiplexed technology makes it possible to test multiple disease markers in a single test simultaneously – with higher sensitivity, faster throughput, and reduced turn-around time.

The company’s lead product, PictArray™ SARS-CoV-2 IgG ELISA Kit, enables more informed clinical interventions to reduce the threat of COVID-19.

Pictor partners with Mobility Health, USA, to launch the PictArray™ SARS-CoV-2 Antibody Test on the US Market

Pictor’s multiplex platform allows multiple analytes to be detected in one test. This has been applied in the PictArrayTM SARS-CoV-2 ELISA Test to detect IgG antibodies to both the Spike Protein and Nucleocapsid Protein in a single test leading to better health outcomes through earlier diagnosis, prevention and treatment.


Read the latest News, Articles and Publications 

Pictor announces strategic collaboration with BICO Group’s SCIENION for international commercialisation of a high throughput SARS-CoV-2 antibody testing system using the PictArrayTM SARS-CoV-2 ELISA Kit with SCIENION’s sciREADER CL2 imager